Don't take this medicine. The post Common Cholesterol Medication Recalled Over ‘Failed’ Testing appeared first on Mandatory.

Over 140,000 bottles of atorvastatin calcium tablets—the generic version of Lipitor—were pulled from shelves across all 50 U.S. states beginning September 19, 2025, after routine quality checks revealed a critical problem: the tablets failed dissolution tests,

The recall comes after the maker determined the drug may not dissolve or release its active ingredient in a way that meets regulations and standards.

Your prescription may be involved. The FDA explains why suddenly stopping your medication is more harmful than taking it.

FDA announces Atorvastatin recall affecting over 140,000 bottles of cholesterol medication due to failed dissolution specs that could reduce effectiveness.

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 about an extensive recall of thousands of bottles of atorvastatin, the generic version of Lipitor.

Ascend Laboratories, LLC, a New Jersey-based pharmaceutical company, has recalled over 141,000 bottles of cholesterol medication. An advisory from the company suggests that the drugs may have failed to dissolve at a standard rate.

The latest recall affects a generic versions of the statin medication Atorvastatin Calcium, a medication taken by around 47 million Americans to lower “bad” cholesterol, according to Yale Medicine. The drug is being recalled nationwide after quality failures — here’s what you need to know.

The FDA has issued a nationwide recall of Atorvastatin Calcium, the generic form of Lipitor, due to some pills potentially failing to dissolve properly, which could reduce their effectiveness in lowering cholesterol.